MCID: HMP001
MIFTS: 48

Hemopericardium

Categories: Blood diseases, Cardiovascular diseases

Aliases & Classifications for Hemopericardium

MalaCards integrated aliases for Hemopericardium:

Name: Hemopericardium 12 15 17 71
Pericardial Effusion 43 71
Haemopericardium 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11482
ICD9CM 34 423.0
MeSH 43 D010490
NCIt 49 C111644
SNOMED-CT 67 23412002
ICD10 32 I31.2
UMLS 71 C0019064 C0031039

Summaries for Hemopericardium

Disease Ontology : 12 A pericardial effusion that results from blood in the pericardial sac.

MalaCards based summary : Hemopericardium, also known as pericardial effusion, is related to pericardial effusion and mediastinitis. An important gene associated with Hemopericardium is F2 (Coagulation Factor II, Thrombin), and among its related pathways/superpathways are Formation of Fibrin Clot (Clotting Cascade) and Complement and coagulation cascades. The drugs Diclofenac and Tadalafil have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and breast, and related phenotypes are cardiovascular system and respiratory system

Wikipedia : 74 Hemopericardium refers to blood in the pericardial sac of the heart. It is clinically similar to a... more...

Related Diseases for Hemopericardium

Diseases related to Hemopericardium via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 785, show less)
# Related Disease Score Top Affiliating Genes
1 pericardial effusion 30.9 TNNI3 PVR F3 F2
2 mediastinitis 30.7 F3 F2
3 cardiac tamponade 30.7 TNNI3 PVR PLG F3 F2
4 pleural empyema 30.6 PLG F2
5 exanthem 30.5 F3 F2 CYP3A4
6 tricuspid valve insufficiency 30.5 TNNI3 F3 F2
7 pulmonary embolism 30.4 TNNI3 F3 F2
8 anuria 30.4 F3 F2
9 inferior myocardial infarction 30.3 TNNI3 PLG
10 thrombophlebitis 30.2 PLG F3 F2
11 mitral valve stenosis 30.2 F3 F2
12 esophageal varix 30.2 F3 F2
13 intermediate coronary syndrome 30.1 TNNI3 PLG F3
14 acute myocardial infarction 30.1 TNNI3 PLG F3
15 hemophilia b 30.1 FBN1 F3 F2
16 heart valve disease 30.0 TNNI3 FBN1 F2
17 stroke, ischemic 30.0 PLG FBN1 F3 F2
18 aortic valve insufficiency 30.0 TNNI3 FBN1
19 mitral valve insufficiency 30.0 TNNI3 FBN1 F2
20 thrombosis 30.0 PLG F3 F2
21 mitral valve disease 29.9 TNNI3 FBN1 F3 F2
22 hepatitis a 29.8 F3 F2 CYP3A4
23 angina pectoris 29.7 TNNI3 F3
24 intracranial embolism 29.6 PVR PLG F3 F2
25 tricuspid valve disease 29.5 TNNI3 FBN1 F3 F2
26 atrial heart septal defect 29.4 TNNI3 PVR PLG FBN1 F3 F2
27 atrial fibrillation 29.1 TNNI3 F3 F2
28 hypertension, essential 28.7 TNNI3 PLG FBN1 F3 F2 CYP3A4
29 pericardial effusion, chronic 12.7
30 pericardial tuberculosis 11.7
31 hereditary multiple osteochondromas 11.7
32 cantu syndrome 11.7
33 lymphatic malformation 6 11.6
34 camptodactyly-arthropathy-coxa vara-pericarditis syndrome 11.4
35 congenital disorder of glycosylation, type ia 11.4
36 congenital disorder of glycosylation, type ie 11.4
37 kaposiform lymphangiomatosis 11.4
38 hypothyroidism 10.8
39 pericarditis 10.6
40 aortic dissection 10.5
41 myxedema 10.5
42 constrictive pericarditis 10.5
43 benign mesothelioma 10.5
44 down syndrome 10.5
45 kidney disease 10.5
46 myocarditis 10.5
47 cardiac rupture 10.4
48 atrial standstill 1 10.4
49 pulmonary hypertension 10.4
50 connective tissue disease 10.4
51 achenbach syndrome 10.4 F3 F2
52 lymphoma 10.4
53 end stage renal disease 10.4
54 fournier gangrene 10.4 F3 F2
55 synovial angioma 10.4 F3 F2
56 renal pelvis squamous cell carcinoma 10.4 F3 F2
57 papillary adenofibroma 10.4 F3 F2
58 blue toe syndrome 10.4 F3 F2
59 emphysematous cholecystitis 10.4 F3 F2
60 aneurysm 10.4
61 femoral neuropathy 10.4 F3 F2
62 lateral sinus thrombosis 10.4 F3 F2
63 pulmonary hypertension, primary, 1 10.4
64 sarcoidosis 1 10.4
65 giant hemangioma 10.4 F3 F2
66 dic in newborn 10.4 F3 F2
67 waterhouse-friderichsen syndrome 10.4 F3 F2
68 cavernous sinus thrombosis 10.4 F3 F2
69 lemierre's syndrome 10.4 F3 F2
70 gastric hemangioma 10.4 F3 F2
71 hepatic infarction 10.4 F3 F2
72 qualitative platelet defect 10.4 F3 F2
73 myocardial infarction 10.4
74 ankylosing spondylitis 1 10.4 F3 F2
75 epidural abscess 10.4 F3 F2
76 cerebral sinovenous thrombosis 10.4 F3 F2
77 prothrombin deficiency 10.4 F3 F2
78 esophageal cancer 10.4
79 scleroderma, familial progressive 10.4
80 lung cancer 10.4
81 myeloma, multiple 10.4
82 systemic scleroderma 10.4
83 hypereosinophilic syndrome 10.4
84 kidney cortex necrosis 10.4 PLG F2
85 livedoid vasculitis 10.4 PLG F2
86 intracranial hypotension 10.4 F3 F2
87 thoracic outlet syndrome 10.4 PLG F2
88 splenic infarction 10.4 F3 F2
89 medulloadrenal hyperfunction 10.4 PLG F3
90 splenic sequestration 10.4 F3 F2
91 graft-versus-host disease 10.4
92 adenocarcinoma 10.4
93 hepatic coma 10.4 F3 F2
94 cholesterol embolism 10.4 PLG F2
95 branch retinal artery occlusion 10.3 PLG F2
96 retinal artery occlusion 10.3 PLG F2
97 acute hemorrhagic encephalitis 10.3 F3 F2
98 virus-associated trichodysplasia spinulosa 10.3
99 vitamin k deficiency bleeding 10.3 F3 F2
100 analbuminemia 10.3 F3 F2
101 hantavirus pulmonary syndrome 10.3 F3 F2
102 acute cor pulmonale 10.3 PLG F3
103 central retinal artery occlusion 10.3 PLG F2
104 acute pulmonary heart disease 10.3 PLG F3
105 endocarditis 10.3
106 hemarthrosis 10.3 F3 F2
107 lung cancer susceptibility 3 10.3
108 pancreatitis 10.3
109 amyloidosis 10.3
110 intracranial hypertension, idiopathic 10.3 F3 F2
111 thrombasthenia 10.3 F3 F2
112 leech infestation 10.3 PLG F3
113 von willebrand disease, type 1 10.3 F3 F2
114 leukemia, acute lymphoblastic 10.3
115 respiratory failure 10.3
116 thyroiditis 10.3
117 infective endocarditis 10.3
118 posterior cerebral artery infarction 10.3 PLG F3
119 papilledema 10.3 F3 F2
120 rheumatoid arthritis 10.3
121 arthritis 10.3
122 factor x deficiency 10.3 F3 F2
123 primary thrombocytopenia 10.3 F3 F2
124 small cell cancer of the lung 10.3
125 anorexia nervosa 10.3
126 erdheim-chester disease 10.3
127 acquired immunodeficiency syndrome 10.3
128 b-cell lymphoma 10.3
129 vasculitis 10.3
130 factor v deficiency 10.3 F3 F2
131 peripheral vertigo 10.3 F3 F2
132 occlusion precerebral artery 10.3 PLG F3
133 factor xiii deficiency 10.3 F3 F2
134 purpura fulminans 10.3 F3 F2
135 immune deficiency disease 10.3
136 thymoma, familial 10.3
137 hereditary lymphedema i 10.3
138 brucellosis 10.3
139 thymoma 10.3
140 teratoma 10.3
141 cardiac diverticulum 10.3
142 chromosomal triplication 10.3
143 pulmonary valve disease 10.2 PVR FBN1
144 retinal vascular occlusion 10.2 PLG F2
145 fibrosis of extraocular muscles, congenital, 1 10.2
146 temporal arteritis 10.2
147 lymphoma, hodgkin, classic 10.2
148 endometrial cancer 10.2
149 graves' disease 10.2
150 endomyocardial fibrosis 10.2
151 vascular disease 10.2
152 pulmonary tuberculosis 10.2
153 histiocytosis 10.2
154 pericardial mesothelioma 10.2
155 chronic graft versus host disease 10.2
156 raynaud phenomenon 10.2
157 cardiac arrest 10.2
158 aortic aneurysm 10.2
159 ceftriaxone allergy 10.2 HCCS F3
160 aspiration pneumonia 10.2 F3 F2
161 ovarian cancer 10.2
162 langerhans cell histiocytosis 10.2
163 human immunodeficiency virus type 1 10.2
164 acute pancreatitis 10.2
165 liver cirrhosis 10.2
166 hemangioendothelioma 10.2
167 syncope 10.2
168 factor viii deficiency 10.2 F3 F2
169 marantic endocarditis 10.2 PLG F3 F2
170 intracranial sinus thrombosis 10.2 PLG F3 F2
171 sagittal sinus thrombosis 10.2 PLG F3 F2
172 cerebral falx meningioma 10.2 PLG F3 F2
173 alpha-2-plasmin inhibitor deficiency 10.2 PLG F3 F2
174 post-thrombotic syndrome 10.2 PLG F3 F2
175 intracranial thrombosis 10.2 PLG F3 F2
176 thrombophilia due to activated protein c resistance 10.2 PLG F3 F2
177 compartment syndrome 10.2 PLG F3 F2
178 antithrombin iii deficiency 10.2 PLG F3 F2
179 central retinal vein occlusion 10.2 PLG F3 F2
180 coronary thrombosis 10.2 PLG F3 F2
181 autoimmune disease of cardiovascular system 10.2 PLG F3 F2
182 inherited blood coagulation disease 10.2 PLG F3 F2
183 blood coagulation disease 10.2 PLG F3 F2
184 endocardium disease 10.2 PLG F3 F2
185 hepatic vascular disease 10.2 PLG F3 F2
186 vein disease 10.2 PLG F3 F2
187 moyamoya disease 1 10.2 PLG F3 F2
188 hashimoto thyroiditis 10.1
189 lipomatosis, multiple 10.1
190 familial mediterranean fever 10.1
191 lymphoma, non-hodgkin, familial 10.1
192 kawasaki disease 10.1
193 deficiency anemia 10.1
194 atrioventricular block 10.1
195 pleomorphic lipoma 10.1
196 nephrotic syndrome 10.1
197 churg-strauss syndrome 10.1
198 pneumonia 10.1
199 juvenile rheumatoid arthritis 10.1
200 meningitis 10.1
201 allergic angiitis 10.1
202 lymphosarcoma 10.1
203 splenomegaly 10.1
204 afibrinogenemia, congenital 10.1 PLG F3 F2
205 factor xi deficiency 10.1 F3 F2
206 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.1
207 aortitis 10.1
208 disseminated intravascular coagulation 10.1 PLG F3 F2
209 cortical blindness 10.1 F3 F2
210 hepatocellular carcinoma 10.1
211 kaposi sarcoma 10.1
212 yellow nail syndrome 10.1
213 mesothelioma, malignant 10.1
214 graves disease 1 10.1
215 anemia, x-linked, with or without neutropenia and/or platelet abnormalities 10.1
216 orthostatic intolerance 10.1
217 cyanosis, transient neonatal 10.1
218 melioidosis 10.1
219 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 10.1
220 drug-induced lupus erythematosus 10.1
221 small cell carcinoma 10.1
222 rheumatic heart disease 10.1
223 lymphoblastic lymphoma 10.1
224 pleurisy 10.1
225 paragonimiasis 10.1
226 hypoparathyroidism 10.1
227 squamous cell carcinoma 10.1
228 bronchiolitis 10.1
229 thymic carcinoma 10.1
230 mixed connective tissue disease 10.1
231 pulmonary fibrosis 10.1
232 lung disease 10.1
233 47,xyy 10.1
234 al amyloidosis 10.1
235 lymphangiectasis 10.1
236 polymyositis 10.1
237 dysphagia 10.1
238 active peptic ulcer disease 10.1 F3 F2 CYP3A4
239 speech and communication disorders 10.1 PLG F3 F2
240 protein s deficiency 10.1 F3 F2
241 bilirubin metabolic disorder 10.1 F3 F2 CYP3A4
242 pectus excavatum 10.1
243 patent ductus arteriosus 1 10.1
244 angiosarcoma 10.1
245 pulmonary edema 10.1
246 heart disease 10.1
247 leukemia 10.1
248 thrombocytopenia 10.1
249 ventricular septal defect 10.1
250 heart septal defect 10.1
251 hemangioma 10.1
252 hemophilia 10.1
253 cardiogenic shock 10.1
254 aortic valve disease 1 10.1
255 coronary artery dissection, spontaneous 10.1
256 lymphangioleiomyomatosis 10.1
257 leukemia, chronic myeloid 10.1
258 intracranial aneurysm 10.1
259 lymphadenitis 10.1
260 chronic kidney disease 10.1
261 osteonecrosis 10.1 PLG F2 CYP3A4
262 renal cell carcinoma, nonpapillary 10.0
263 myositis 10.0
264 celiac disease 1 10.0
265 hydrops fetalis, nonimmune 10.0
266 leukemia, acute myeloid 10.0
267 pulmonary disease, chronic obstructive 10.0
268 coronary heart disease 1 10.0
269 mycobacterium tuberculosis 1 10.0
270 kala-azar 1 10.0
271 myelodysplastic syndrome 10.0
272 congenital hypothyroidism 10.0
273 autosomal recessive disease 10.0
274 diffuse large b-cell lymphoma 10.0
275 polycystic kidney disease 10.0
276 igg4-related disease 10.0
277 dermatomyositis 10.0
278 thalassemia 10.0
279 allergic hypersensitivity disease 10.0
280 poems syndrome 10.0
281 toxic shock syndrome 10.0
282 myeloproliferative neoplasm 10.0
283 endometrial adenocarcinoma 10.0
284 cryoglobulinemia 10.0
285 rhabdomyosarcoma 10.0
286 ischemia 10.0
287 pituitary adenoma 10.0
288 restrictive cardiomyopathy 10.0
289 adenoma 10.0
290 myeloid sarcoma 10.0
291 leishmaniasis 10.0
292 hypopituitarism 10.0
293 48,xyyy 10.0
294 cytokine deficiency 10.0
295 germ cells tumors 10.0
296 lymphoma aids related 10.0
297 cytomegalovirus infection 10.0
298 primary mediastinal large b-cell lymphoma 10.0
299 thyroid carcinoma 10.0
300 intracranial berry aneurysm 10.0 TNNI3 PLG F3
301 orbital disease 10.0 HEG1 FBN1
302 common bile duct disease 10.0 F2 ERVMER34-1
303 factor vii deficiency 10.0 F3 F2
304 alcohol dependence 10.0
305 leukemia, chronic lymphocytic 10.0
306 pheochromocytoma 10.0
307 acyl-coa dehydrogenase, very long-chain, deficiency of 10.0
308 takayasu arteritis 10.0
309 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.0
310 myasthenia gravis 10.0
311 ocular motor apraxia 10.0
312 sarcoma, synovial 10.0
313 atrioventricular septal defect 10.0
314 body mass index quantitative trait locus 1 10.0
315 aortic aneurysm, familial thoracic 1 10.0
316 ovarian hyperstimulation syndrome 10.0
317 legionnaire disease 10.0
318 granulomatosis with polyangiitis 10.0
319 hepatitis c virus 10.0
320 pulmonary hypertension, chronic thromboembolic, without deep vein thrombosis 10.0
321 aspergillosis 10.0
322 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.0
323 juvenile arthritis 10.0
324 hemophagocytic lymphohistiocytosis 10.0
325 sleep apnea 10.0
326 fibroma 10.0
327 adrenal gland pheochromocytoma 10.0
328 lymphoproliferative syndrome 10.0
329 meningococcal meningitis 10.0
330 chronic myelomonocytic leukemia 10.0
331 sensorineural hearing loss 10.0
332 sparganosis 10.0
333 q fever 10.0
334 microcytic anemia 10.0
335 ornithosis 10.0
336 hypertensive heart disease 10.0
337 hemosiderosis 10.0
338 oligohydramnios 10.0
339 primary biliary cirrhosis 10.0
340 diarrhea 10.0
341 cardiac sarcoidosis 10.0
342 kwashiorkor 10.0
343 cholestasis 10.0
344 polyneuropathy 10.0
345 adult-onset still's disease 10.0
346 diffuse scleroderma 10.0
347 rheumatic fever 10.0
348 histoplasmosis 10.0
349 hepatitis c 10.0
350 melanoma 10.0
351 gaucher's disease 10.0
352 leiomyosarcoma 10.0
353 constipation 10.0
354 gastroenteritis 10.0
355 acromegaly 10.0
356 cystic teratoma 10.0
357 endometriosis 10.0
358 interstitial lung disease 10.0
359 papillary carcinoma 10.0
360 lipid metabolism disorder 10.0
361 neurilemmoma 10.0
362 ovary adenocarcinoma 10.0
363 myopathy 10.0
364 non-langerhans-cell histiocytosis 10.0
365 pustulosis of palm and sole 10.0
366 alcoholic pancreatitis 10.0
367 t-cell acute lymphoblastic leukemia 10.0
368 tricuspid valve prolapse 10.0
369 t-cell lymphoblastic leukemia/lymphoma 10.0
370 situs inversus 10.0
371 influenza 10.0
372 ulcerative colitis 10.0
373 hodgkin's granuloma 10.0
374 eating disorder 10.0
375 neuropathy 10.0
376 crohn's disease 10.0
377 psoriasis 10.0
378 autosomal dominant polycystic kidney disease 10.0
379 diabetes insipidus 10.0
380 bacterial meningitis 10.0
381 heart aneurysm 10.0
382 diastolic heart failure 10.0
383 muscular dystrophy 10.0
384 chronic thromboembolic pulmonary hypertension 10.0
385 dextrocardia with situs inversus 10.0
386 kaposiform hemangioendothelioma 10.0
387 leukemia, t-cell, chronic 10.0
388 lymphangiomatosis 10.0
389 macrophage activation syndrome 10.0
390 retroperitoneal fibrosis 10.0
391 systemic onset juvenile idiopathic arthritis 10.0
392 mixed germ cell tumor 10.0
393 b-cell non-hodgkin lymphoma 10.0
394 rare hereditary hemochromatosis 10.0
395 ovarian fibroma 10.0
396 arteries, anomalies of 9.9 TNNI3 PLG F3
397 aortic aneurysm, familial abdominal, 1 9.9
398 autoimmune disease 9.9
399 blue rubber bleb nevus 9.9
400 breast cancer 9.9
401 cardiac conduction defect 9.9
402 coarctation of aorta 9.9
403 diaphragmatic hernia, congenital 9.9
404 systemic lupus erythematosus 9.9
405 anemia, autoimmune hemolytic 9.9
406 chondrosarcoma 9.9
407 hemangiopericytoma, malignant 9.9
408 polycythemia vera 9.9
409 respiratory distress syndrome in premature infants 9.9
410 paraganglioma 9.9
411 chronic neutrophilic leukemia 9.9
412 silicosis 9.9
413 caplan's syndrome 9.9
414 dressler's syndrome 9.9
415 sarcoma 9.9
416 pericardium cancer 9.9
417 nephrosclerosis 9.9
418 hypertrophic cardiomyopathy 9.9
419 chagas disease 9.9
420 neutropenia 9.9
421 newborn respiratory distress syndrome 9.9
422 dilated cardiomyopathy 9.9
423 acute cystitis 9.9
424 thrombocytopenia due to platelet alloimmunization 9.9
425 pneumothorax 9.9
426 essential thrombocythemia 9.9
427 acute kidney failure 9.9
428 coronary aneurysm 9.9
429 spindle cell sarcoma 9.9
430 seminoma 9.9
431 subacute bacterial endocarditis 9.9
432 uremia 9.9
433 arteriolosclerosis 9.9
434 aortic disease 9.9
435 subvalvular aortic stenosis 9.9
436 hemolytic anemia 9.9
437 congestive heart failure 9.9
438 paraplegia 9.9
439 plasma cell neoplasm 9.9
440 hyperthyroidism 9.9
441 polycythemia 9.9
442 collagen disease 9.9
443 myeloid leukemia 9.9
444 subacute myeloid leukemia 9.9
445 lupus erythematosus 9.9
446 evans' syndrome 9.9
447 coronary artery aneurysm 9.9
448 spinal cord injury 9.9
449 thrombotic microangiopathy 9.9
450 pericardium disease 9.9 TNNI3 PVR F3 F2
451 choledocholithiasis 9.9 F2 ERVMER34-1
452 lipoprotein quantitative trait locus 9.9 TNNI3 PLG F3 F2
453 cecal disease 9.8 F3 F2 ERVMER34-1
454 pfeiffer syndrome 9.8
455 spondyloarthropathy 1 9.8
456 apnea, obstructive sleep 9.8
457 atherosclerosis susceptibility 9.8
458 behcet syndrome 9.8
459 progressive familial heart block, type ia 9.8
460 colorectal cancer 9.8
461 cardiac arrhythmia 9.8
462 carpal tunnel syndrome 9.8
463 cryoglobulinemia, familial mixed 9.8
464 epidermoid cysts 9.8
465 hypercholesterolemia, familial, 1 9.8
466 ige responsiveness, atopic 9.8
467 kabuki syndrome 1 9.8
468 macroglossia 9.8
469 migraine with or without aura 1 9.8
470 pelger-huet anomaly 9.8
471 pernicious anemia 9.8
472 pneumothorax, primary spontaneous 9.8
473 poland syndrome 9.8
474 polykaryocytosis inducer 9.8
475 prostate cancer 9.8
476 dowling-degos disease 1 9.8
477 schizophrenia 9.8
478 tetralogy of fallot 9.8
479 digeorge syndrome 9.8
480 tracheoesophageal fistula with or without esophageal atresia 9.8
481 suppressor of tumorigenicity 3 9.8
482 varicose veins 9.8
483 acrocallosal syndrome 9.8
484 ascites, chylous 9.8
485 atrioventricular dissociation 9.8
486 cystic fibrosis 9.8
487 endocardial fibroelastosis 9.8
488 gastroschisis 9.8
489 heart block, congenital 9.8
490 hydrocephalus, congenital, 1 9.8
491 myelofibrosis 9.8
492 netherton syndrome 9.8
493 niemann-pick disease, type c1 9.8
494 3-methylglutaconic aciduria, type iii 9.8
495 pituitary hormone deficiency, combined, 2 9.8
496 rhabdomyosarcoma, embryonal, 1 9.8
497 rheumatic fever-related antigen 9.8
498 sjogren syndrome 9.8
499 sudden infant death syndrome 9.8
500 tardive dyskinesia 9.8
501 adrenoleukodystrophy 9.8
502 hemophilia a 9.8
503 muscular dystrophy, duchenne type 9.8
504 thoracoabdominal syndrome 9.8
505 suppression of tumorigenicity 12 9.8
506 branchiootic syndrome 1 9.8
507 chylothorax, congenital 9.8
508 omenn syndrome 9.8
509 sickle cell anemia 9.8
510 cervical cancer 9.8
511 renal cell carcinoma, papillary, 1 9.8
512 hypereosinophilic syndrome, idiopathic 9.8
513 ovarian cancer 1 9.8
514 mycobacterium tuberculosis 2 9.8
515 malaria 9.8
516 congenital disorder of glycosylation, type in 9.8
517 major affective disorder 8 9.8
518 major affective disorder 9 9.8
519 myxoid liposarcoma 9.8
520 gastric cancer 9.8
521 beta-thalassemia 9.8
522 psoriasis 14, pustular 9.8
523 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 9.8
524 leukemia, acute lymphoblastic 3 9.8
525 melanoma, cutaneous malignant 10 9.8
526 chlamydia pneumonia 9.8
527 chikungunya 9.8
528 arrhythmogenic right ventricular cardiomyopathy 9.8
529 adult t-cell leukemia 9.8
530 arterial calcification of infancy 9.8
531 peripheral t-cell lymphoma 9.8
532 metabolic acidosis 9.8
533 tongue squamous cell carcinoma 9.8
534 immunoglobulin alpha deficiency 9.8
535 aphasia 9.8
536 colitis 9.8
537 crest syndrome 9.8
538 ptosis 9.8
539 omphalocele 9.8
540 bacillary angiomatosis 9.8
541 hennekam syndrome 9.8
542 cardiac tuberculosis 9.8
543 salmonellosis 9.8
544 wet beriberi 9.8
545 childhood acute lymphocytic leukemia 9.8
546 adenoid cystic carcinoma 9.8
547 malignant pheochromocytoma 9.8
548 tongue carcinoma 9.8
549 hypogonadotropic hypogonadism 9.8
550 acquired von willebrand syndrome 9.8
551 angioimmunoblastic t-cell lymphoma 9.8
552 multicentric castleman disease 9.8
553 castleman disease 9.8
554 asbestosis 9.8
555 chronic leukemia 9.8
556 bacterial infectious disease 9.8
557 diaphragmatic eventration 9.8
558 viral pneumonia 9.8
559 pre-eclampsia 9.8
560 pleural tuberculosis 9.8
561 glucose intolerance 9.8
562 rickets 9.8
563 protein-losing enteropathy 9.8
564 hypertrophy of breast 9.8
565 portal hypertension 9.8
566 fiedler's myocarditis 9.8
567 filariasis 9.8
568 malignant hypertension 9.8
569 hydrocephalus 9.8
570 hemiplegia 9.8
571 trench fever 9.8
572 hydronephrosis 9.8
573 chlamydia 9.8
574 pituitary apoplexy 9.8
575 arteriovenous malformation 9.8
576 diphtheria 9.8
577 hypertensive retinopathy 9.8
578 lyme disease 9.8
579 iron deficiency anemia 9.8
580 protein-energy malnutrition 9.8
581 multicentric reticulohistiocytosis 9.8
582 conn's syndrome 9.8
583 cryptococcosis 9.8
584 inflammatory spondylopathy 9.8
585 dengue disease 9.8
586 dengue hemorrhagic fever 9.8
587 plica syndrome 9.8
588 marasmus 9.8
589 pancytopenia 9.8
590 von willebrand's disease 9.8
591 acute kidney tubular necrosis 9.8
592 acute leukemia 9.8
593 hereditary hemorrhagic telangiectasia 9.8
594 telangiectasis 9.8
595 alcoholic cardiomyopathy 9.8
596 persistent fetal circulation syndrome 9.8
597 severe pre-eclampsia 9.8
598 hellp syndrome 9.8
599 uveitis 9.8
600 gout 9.8
601 typhoid fever 9.8
602 eclampsia 9.8
603 beriberi 9.8
604 sick sinus syndrome 9.8
605 squamous cell papilloma 9.8
606 facial paralysis 9.8
607 alcoholic liver cirrhosis 9.8
608 niemann-pick disease 9.8
609 echinococcosis 9.8
610 panniculitis 9.8
611 pleural disease 9.8
612 urticaria 9.8
613 alcohol use disorder 9.8
614 limited scleroderma 9.8
615 neuroendocrine tumor 9.8
616 duodenal ulcer 9.8
617 hypogonadism 9.8
618 rectum cancer 9.8
619 lutembacher's syndrome 9.8
620 hereditary multiple exostoses 9.8
621 tularemia 9.8
622 thrombocytosis 9.8
623 granulomatous hepatitis 9.8
624 arteriosclerosis 9.8
625 iron metabolism disease 9.8
626 macrocytic anemia 9.8
627 wernicke encephalopathy 9.8
628 agammaglobulinemia 9.8
629 larynx cancer 9.8
630 papilloma 9.8
631 kidney cancer 9.8
632 transitional cell carcinoma 9.8
633 liver angiosarcoma 9.8
634 synovitis 9.8
635 cervix carcinoma 9.8
636 glomerulonephritis 9.8
637 antiphospholipid syndrome 9.8
638 cystadenocarcinoma 9.8
639 gallbladder cancer 9.8
640 lipomatosis 9.8
641 chronic granulomatous disease 9.8
642 bipolar disorder 9.8
643 purpura 9.8
644 fibrosarcoma of bone 9.8
645 liposarcoma 9.8
646 inappropriate adh syndrome 9.8
647 cellulitis 9.8
648 signet ring cell adenocarcinoma 9.8
649 ovarian cystadenocarcinoma 9.8
650 empty sella syndrome 9.8
651 lactic acidosis 9.8
652 plasmacytoma 9.8
653 lung squamous cell carcinoma 9.8
654 mediastinal lipomatosis 9.8
655 acute myocarditis 9.8
656 bladder urothelial carcinoma 9.8
657 tricuspid valve stenosis 9.8
658 hypertrichosis 9.8
659 clear cell sarcoma 9.8
660 carcinosarcoma 9.8
661 ebola hemorrhagic fever 9.8
662 neuromuscular disease 9.8
663 juvenile xanthogranuloma 9.8
664 clear cell adenocarcinoma 9.8
665 mucoepidermoid carcinoma 9.8
666 proliferative glomerulonephritis 9.8
667 cavernous hemangioma 9.8
668 bronchiolo-alveolar adenocarcinoma 9.8
669 thyroid gland disease 9.8
670 heart sarcoma 9.8
671 epithelioid leiomyosarcoma 9.8
672 pituitary gland disease 9.8
673 gingival hypertrophy 9.8
674 t-cell adult acute lymphocytic leukemia 9.8
675 salpingitis 9.8
676 peripheral nervous system disease 9.8
677 anterolateral myocardial infarction 9.8
678 lateral myocardial infarction 9.8
679 eosinophilic pneumonia 9.8
680 bronchitis 9.8
681 lymphopenia 9.8
682 uterine carcinosarcoma 9.8
683 conjunctivitis 9.8
684 ectopic thymus 9.8
685 hypersplenism 9.8
686 pulmonary valve stenosis 9.8
687 spondylitis 9.8
688 mediastinal malignant lymphoma 9.8
689 anthrax disease 9.8
690 malignant pleural mesothelioma 9.8
691 diverticulitis 9.8
692 childhood leukemia 9.8
693 benign mediastinal neurilemmoma 9.8
694 peritonitis 9.8
695 appendicitis 9.8
696 actinomycosis 9.8
697 polyhydramnios 9.8
698 oropharynx cancer 9.8
699 chickenpox 9.8
700 neurofibromatosis 9.8
701 bacterial pneumonia 9.8
702 erythema infectiosum 9.8
703 skin melanoma 9.8
704 visceral leishmaniasis 9.8
705 achalasia 9.8
706 amebiasis 9.8
707 fatty liver disease 9.8
708 sheehan syndrome 9.8
709 plasma cell leukemia 9.8
710 bronchiectasis 9.8
711 dextrocardia 9.8
712 aphthous stomatitis 9.8
713 bacterial conjunctivitis 9.8
714 toxoplasmosis 9.8
715 dystrophinopathies 9.8
716 acquired hemophilia 9.8
717 acquired hemophilia a 9.8
718 acute graft versus host disease 9.8
719 acute monoblastic leukemia 9.8
720 adrenomyeloneuropathy 9.8
721 autoimmune enteropathy 9.8
722 broken heart syndrome 9.8
723 bronchogenic cyst 9.8
724 bronchopulmonary dysplasia 9.8
725 central congenital hypothyroidism 9.8
726 chromophil renal cell carcinoma 9.8
727 chronic active epstein-barr virus infection 9.8
728 congenital cytomegalovirus 9.8
729 congenital lymphedema 9.8
730 cytomegalic inclusion disease 9.8
731 eisenmenger syndrome 9.8
732 granulocytopenia 9.8
733 growth hormone deficiency 9.8
734 haemophilus influenzae 9.8
735 hereditary amyloidosis 9.8
736 homologous wasting disease 9.8
737 kocher-debre-semelaigne syndrome 9.8
738 mitral valve prolapse, familial, x-linked 9.8
739 mycobacterium chelonae 9.8
740 neisseria meningitidis infection 9.8
741 nonseminomatous germ cell tumor 9.8
742 ovarian epithelial cancer 9.8
743 periodontal ehlers-danlos syndrome 9.8
744 post-transplant lymphoproliferative disease 9.8
745 pseudo pelger-huet anomaly 9.8
746 pustular psoriasis 9.8
747 rat bite fever 9.8
748 remitting seronegative symmetrical synovitis with pitting edema 9.8
749 rosai-dorfman disease 9.8
750 sudden sensorineural hearing loss 9.8
751 tetraploidy 9.8
752 undifferentiated connective tissue disease 9.8
753 abdominal wall defect 9.8
754 angiomatosis 9.8
755 anoxia 9.8
756 back pain 9.8
757 cerebral beriberi 9.8
758 encephalopathy 9.8
759 headache 9.8
760 pituitary tumors 9.8
761 posttransplant acute limbic encephalitis 9.8
762 asbestos intoxication 9.8
763 systemic autoimmune disease 9.8
764 rare systemic disease 9.8
765 rare hypothyroidism 9.8
766 congenital left ventricular aneurysm 9.8
767 rapidly involuting congenital hemangioma 9.8
768 epithelioid hemangioendothelioma 9.8
769 pulmonary arterial hypertension associated with connective tissue disease 9.8
770 qualitative or quantitative defects of dystrophin 9.8
771 muscular pseudohypertrophy-hypothyroidism syndrome 9.8
772 gonadal germ cell tumor 9.8
773 igg4-related thyroid disease 9.8
774 benign idiopathic neonatal seizures 9.8
775 primary lymphedema 9.8
776 diffuse alveolar hemorrhage 9.8
777 rare tumor 9.8
778 severe immune-mediated enteropathy 9.8
779 right aortic arch 9.8
780 precursor t-cell acute lymphoblastic leukemia 9.8
781 paralytic ileus 9.7 F2 ERVMER34-1 CYP3A4
782 heart conduction disease 9.6 TNNI3 PVR PLG F3 F2
783 pulmonary artery disease 9.5 TNNI3 PLG F3 F2 CYP3A4
784 hemopneumothorax 9.4 HCCS F3 F2 ERVMER34-1
785 patent foramen ovale 9.4 TNNI3 PVR PLG FBN1 F3 F2

Comorbidity relations with Hemopericardium via Phenotypic Disease Network (PDN): (showing 4, show less)


Aortic Valve Disease 1 Familial Atrial Fibrillation
Heart Disease Intermediate Coronary Syndrome

Graphical network of the top 20 diseases related to Hemopericardium:



Diseases related to Hemopericardium

Symptoms & Phenotypes for Hemopericardium

MGI Mouse Phenotypes related to Hemopericardium:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.5 F2 F3 FBN1 HCCS HEG1 PLG
2 respiratory system MP:0005388 9.1 F2 F3 FBN1 HEG1 PLG TNNI3

Drugs & Therapeutics for Hemopericardium

Drugs for Hemopericardium (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 150, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Diclofenac Approved, Vet_approved Phase 4 15307-86-5 3033
2
Tadalafil Approved, Investigational Phase 4 171596-29-5 110635
3
Ambrisentan Approved, Investigational Phase 4 177036-94-1 6918493
4
Silver sulfadiazine Approved, Vet_approved Phase 4 22199-08-2 441244
5
Treprostinil Approved, Investigational Phase 4 81846-19-7 6918140 54786
6
Colchicine Approved Phase 4 64-86-8 2833 6167
7
Aspirin Approved, Vet_approved Phase 4 50-78-2 2244
8
Prednisone Approved, Vet_approved Phase 4 53-03-2 5865
9
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4 1177-87-3
10
Ibuprofen Approved Phase 4 15687-27-1 3672
11
Dexamethasone Approved, Investigational, Vet_approved Phase 4 50-02-2 5743
12
Dabigatran Investigational Phase 4 211914-51-1
13 Analgesics, Non-Narcotic Phase 4
14 Analgesics Phase 4
15 Cyclooxygenase Inhibitors Phase 4
16 Anti-Inflammatory Agents, Non-Steroidal Phase 4
17 Phosphodiesterase 5 Inhibitors Phase 4
18 Phosphodiesterase Inhibitors Phase 4
19 Antithrombins Phase 4
20 Antithrombin III Phase 4
21 Serine Proteinase Inhibitors Phase 4
22
protease inhibitors Phase 4
23 HIV Protease Inhibitors Phase 4
24 Anticoagulants Phase 4
25 Anti-Inflammatory Agents Phase 4
26 Hormones Phase 4
27 Antineoplastic Agents, Hormonal Phase 4
28 glucocorticoids Phase 4
29 Hormone Antagonists Phase 4
30 Antiemetics Phase 4
31 Gastrointestinal Agents Phase 4
32
Serine Investigational, Nutraceutical Phase 4 56-45-1 5951
33
Cetrorelix Approved, Investigational Phase 2, Phase 3 120287-85-6 16129715 25074887
34
Bleomycin Approved, Investigational Phase 3 11056-06-7 5360373
35
Prednisolone phosphate Approved, Vet_approved Phase 3 302-25-0
36
Methylprednisolone Approved, Vet_approved Phase 3 83-43-2 6741
37
Methylprednisolone hemisuccinate Approved Phase 3 2921-57-5
38
Prednisolone Approved, Vet_approved Phase 3 50-24-8 5755
39 Prednisolone acetate Approved, Vet_approved Phase 3 52-21-1
40
Prednisolone hemisuccinate Experimental Phase 3 2920-86-7
41 Fibrinolytic Agents Phase 3
42 Tissue Plasminogen Activator Phase 3
43 Plasminogen Phase 3
44 Sclerosing Solutions Phase 3
45 Methylprednisolone Acetate Phase 3
46 Vaccines Phase 3
47 Tubulin Modulators Phase 3
48 Antirheumatic Agents Phase 3
49 Antimitotic Agents Phase 3
50
Bevacizumab Approved, Investigational Phase 2 216974-75-3
51
Cetuximab Approved Phase 2 205923-56-4 56842117 2333
52
Docetaxel Approved, Investigational Phase 2 114977-28-5 148124
53
Cisplatin Approved Phase 1, Phase 2 15663-27-1 2767 441203 84093
54
Etoposide Approved Phase 1, Phase 2 33419-42-0 36462
55
Gemcitabine Approved Phase 2 95058-81-4 60750
56
leucovorin Approved Phase 2 58-05-9 6006 143
57
Pemetrexed Approved, Investigational Phase 2 137281-23-3, 150399-23-8 60843 446556
58
Letrozole Approved, Investigational Phase 2 112809-51-5 3902
59
Everolimus Approved Phase 2 159351-69-6 70789204 6442177
60
Exemestane Approved, Investigational Phase 2 107868-30-4 60198
61
Capecitabine Approved, Investigational Phase 2 154361-50-9 60953
62
Anastrozole Approved, Investigational Phase 2 120511-73-1 2187
63
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
64
Carboplatin Approved Phase 2 41575-94-4 10339178 38904 498142
65
Daunorubicin Approved Phase 2 20830-81-3 30323
66
Dasatinib Approved, Investigational Phase 2 302962-49-8 3062316
67
Cytarabine Approved, Experimental, Investigational Phase 2 147-94-4, 65-46-3 6253
68
Diltiazem Approved, Investigational Phase 2 42399-41-7 39186
69
Celiprolol Approved, Investigational Phase 2 56980-93-9
70
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
71
Rilotumumab Investigational Phase 1, Phase 2 872514-65-3
72 Misonidazole Investigational Phase 2 13551-87-6
73 Angiogenesis Inhibitors Phase 2
74 Antineoplastic Agents, Immunological Phase 2
75 Etoposide phosphate Phase 1, Phase 2
76 Vitamin B Complex Phase 2
77 Folic Acid Antagonists Phase 2
78 Folate Phase 2
79 Vitamin B9 Phase 2
80 Estrogen Receptor Antagonists Phase 2
81 Estrogen Antagonists Phase 2
82 Aromatase Inhibitors Phase 2
83 Estrogens Phase 2
84
Erlotinib Hydrochloride Phase 2 183319-69-9 176871
85 Anti-Bacterial Agents Phase 2
86 Antibiotics, Antitubercular Phase 2
87 Albumin-Bound Paclitaxel Phase 2
88 Immunologic Factors Phase 2
89 Anti-Infective Agents Phase 2
90 Immunosuppressive Agents Phase 2
91 Antiviral Agents Phase 2
92 Antimetabolites Phase 2
93 Protein Kinase Inhibitors Phase 2
94 Fluorodeoxyglucose F18 Phase 2
95 Fluorides Phase 2
96 Antiparasitic Agents Phase 2
97 Antiprotozoal Agents Phase 2
98 Deoxyglucose Phase 2
99 Radiopharmaceuticals Phase 2
100 Anti-Arrhythmia Agents Phase 2
101 Antihypertensive Agents Phase 2
102 Vasodilator Agents Phase 2
103 Adrenergic beta-1 Receptor Antagonists Phase 2
104 Adrenergic Agents Phase 2
105 Adrenergic Antagonists Phase 2
106 Adrenergic beta-Antagonists Phase 2
107 Sympathomimetics Phase 2
108 Neurotransmitter Agents Phase 2
109 Calcium, Dietary Phase 2
110 calcium channel blockers Phase 2
111
Calcium Nutraceutical Phase 2 7440-70-2 271
112
Trastuzumab Approved, Investigational Phase 1 180288-69-1 9903
113
Parathyroid hormone Approved, Investigational Phase 1 9002-64-6
114
tipifarnib Investigational Phase 1 192185-72-1 159324
115 Pancreatic Polypeptide Investigational Phase 1 59763-91-6
116 Adjuvants, Immunologic Phase 1
117 Interleukin-12 Phase 1
118 Cola Phase 1
119
Sotalol Approved 3930-20-9, 959-24-0 5253
120
Dronedarone Approved 141625-93-6, 141626-36-0 154087
121
Disopyramide Approved 3737-09-5 3114
122
Propafenone Approved 54063-53-5 4932
123
Nitric Oxide Approved 10102-43-9 145068
124
Carbon monoxide Approved, Investigational 630-08-0 281
125
Chlorhexidine Approved, Vet_approved 55-56-1 9552079 2713